|
 
|
Fraser Health stroke patients face ‘less than ideal’ care: report
Patients battle time delays if transferred to Vancouver for treatment
Fraser Health hospitals are diverting or transferring stroke patients to Vancouver hospitals, creating “less than ideal” care, according to an external report prepared for the provincial government.
This is despite the fact two hospitals — Royal Columbian and Surrey Memorial — are designated stroke sites and have stroke specialists — including stroke neurologists and other experts — on staff, the review found.
Rapid care is key in the treatment of stroke patients since a special class of drugs called thrombolytics may be used to break up blood clots in the brain that cause ischemic strokes. But they must be administered within 4½ hours from the onset of symptoms to be potentially effective.
So when every minute counts, those in the Fraser Health region who are transported to Vancouver hospitals instead of their nearest local facility face critical time delays, the Fraser Health Review report states.
A Fraser Health medical director downplayed the criticisms in the report on Tuesday, saying steps have been taken to address many of the concerns since the review was conducted, although he acknowledged some patients are still transferred to Vancouver.
“I can’t change what’s written there ... and it’s not a question of disputing it,” said Dr. Dave Williams, Fraser Health’s program medical director of medicine. “But we do use thrombolytics and patients are receiving the best stroke care, whether they go to Royal Columbian or Surrey.”
The Fraser Health Review, ordered by Health Minister Terry Lake last year, was released earlier this month. It flagged numerous areas of concern in the region, including adverse events suffered by patients in hospital and an over-reliance on acute care hospital beds. When it was released, Lake announced an injection of $60 million more over the next two years, on top of the $3.1 billion Fraser Health already receives from the government annually.
The report says the transfer of patients to Vancouver General Hospital from Fraser Health facilities — including Surrey Memorial — also has a negative impact on ambulance resources and patient volume at VGH.
“This is not good patient care as it introduces undue time delays to a treatment that is time sensitive. As well, it impacts (ambulance) resources and it impacts volumes at VGH,” it says.
On the issue of stroke, the report also identified these problems:
• Royal Columbian Hospital “is a designated stroke site, but their emergency (department) is resistant to accepting further volumes given their current capacity issues.”
• At Surrey Memorial, “the emergency department and neurology have not embraced or implemented the use of thrombolytics.”
Thrombolytics — specifically a drug known as tissue plasminogen activator (TPA) — were first approved for use in Canada in 1999. Since then, various advocacy organizations — including the Heart and Stroke Foundation and Canadian Stroke Network — have been agitating for greater awareness of the “time is brain” messaging, improved use of TPA and the need for designated stroke centres.
Yet the Fraser Health Review report says even hospitals designated as stroke sites — Royal Columbian, Surrey Memorial and Abbotsford Regional hospitals — are diverting or transferring stroke patients to Vancouver.
“Fraser Health has not been successful in implementing consistent use of thrombolytics in the emergency departments of designated stroke sites ... As a result, they have not been fully able to implement ambulance bypass to designated stroke sites.”
Williams said he thinks the report was based on outdated information since, in the past year, aggressive efforts have been made to improve stroke care across the region. The report looked at hospital visits in 2012/13.
He believes the report failed to consider efforts such as the hiring of new stroke neurologists, which helps hospitals like RCH provide 24/7 stroke care and consistently offer thrombolytics. |
|